Harmony Biosciences 8-K Report: Key Insights & Filing Details

$HRMY
Form 8-K
Filed on: 2025-02-25
Source
Harmony Biosciences 8-K Report: Key Insights & Filing Details

Here are the key insights extracted from the provided section of the financial report:

  1. Entity Information:
  • Company Name: Harmony Biosciences Holdings, Inc.
  • CIK: 0001802665
  • State of Incorporation: Delaware (DE)
  • SEC File Number: 001-39450
  • EIN: 82-2279923
  • Address: 630 W. Germantown Pike, Suite 215, Plymouth Meeting, PA 19462
  • Phone Number: 484-539-9800
  1. Filing Details:
  • Filing Type: 8-K
  • Filing Date: February 25, 2025
  1. Stock Information:
  • Common Stock Par Value: $0.00001 per share
  • Stock Symbol: HRMY
  • Exchange: NASDAQ
  1. Reporting Period:
  • Start Date: February 25, 2025
  • End Date: February 25, 2025
  1. XML and Schema Reference:
  • The report is structured in XBRL format, and it references an XSD schema file named hrmy-20250225.xsd.

Summary:

This section provides essential details about Harmony Biosciences Holdings, Inc., including its identification information, stock details, and the nature of the financial filing (8-K). The report is a short-period filing dated February 25, 2025, indicating a specific event or change in the company’s status that necessitated reporting to the SEC.